NEW YORK (GenomeWeb) – Color Genomics, which to date has been offering its 30-gene hereditary cancer risk test at a self-pay rate of around $250, said it will begin accepting health insurance starting June 15.
Registering provides access to this and other free content.
Already have an account?Login Now.
This webinar will present an in-depth look at how Memorial Sloan Kettering Cancer Center has developed and implemented a next-generation sequencing panel for mutational tumor profiling of advanced cancer patients.
This webinar will discuss the critical role that software can play for clinical labs looking to establish comprehensive genomic testing programs.
This webinar will be a roundtable discussion on the adoption of a commercial gene panel for tumor profiling at several leading US cancer centers.